GLSI   $13.42  3.47% Market Closed

Greenwich Lifesciences Inc
Total Cash 7.22M
totalCashPerShare 0.55
EBITDA -10.53M
Total Debt 0.00
quickRatio 5.34
currentRatio 5.34
Total Revenue
debtToEquity
Revenue/Share
ROA -0.72453004
ROE -1.2366999
grossProfits
freeCashflow -3.15M
operatingCashflow -6.79M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 172.33M
forwardPE -17.585365
floatShares 5.92M
sharesOutstanding 13.14M
sharesShort 501.22K
sharesShortPriorMonth 505.18K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.53%
heldPercentInstitutions 0.08%
Short Ratio help_outline 16.98%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 0.45
Price To Book help_outline 32.04
earningsQuarterlyGrowth
netIncomeToCommon -10.22M
trailingEps -0.79%
forwardEps -0.82%
enterpriseToEbitda -16.36
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.21 3Q 2024
institutionsCount 58
lastUpdated Nov. 7, 2024, 3:25 a.m.